期刊文献+

脂联素影响骨代谢致骨质疏松症的研究进展 被引量:2

Advances in studies on adiponectin affecting bone metabolism induced osteoporosis
原文传递
导出
摘要 使骨吸收增加或骨形成减少的因素都会诱导骨质疏松症的发生。脂联素作为近年来发现的一种内源性的生物活性多肽类物质,除观察到对糖脂代谢、血管内皮及平滑肌功能、肿瘤坏死因子等方面有作用外,在骨代谢中亦发挥重要作用,可直接或间接地影响骨吸收和骨形成这两大骨代谢方面。脂联素在骨组织中的生理作用的实质是对成骨和破骨两方面综合影响的结果。 At present, the factors which could increase bone absorption or inhitit osteogensis may induce the occurrence of osteoporosis disease. As an endogenous bioactive peptides discovered in recent years, adiponectin has the effect on glycolipid metabolism, function of vascular endothelial and smooth muscle, and tumor necrosis factor. Beyond these, adiponection also plays an important role in bone metabolism that could affect the bone absorption and osteogensis directly or indirectly. As a matter of fact, the action nf adinnnectin in physiological effect of bone tissue is a comprehensive influence on osteogenesis and broken bone essentially.
作者 王磊 李兴
出处 《现代药物与临床》 CAS 2011年第6期426-429,共4页 Drugs & Clinic
关键词 脂联素 骨质疏松 骨形成 骨吸收 adiponectin osteoporosis osteogensis bone absorption
  • 相关文献

参考文献24

  • 1胡军,张华,牟青.骨质疏松症的流行病学趋势与防治进展[J].临床荟萃,2011,26(8):729-731. 被引量:115
  • 2曾婧娉,阎卉,王成港,王春龙.骨质疏松症治疗药物——艾尔骨化醇[J].药物评价研究,2011,34(3):224-229. 被引量:8
  • 3马亚兵,高海青,刘新春,刘萍,王海刚.骨质疏松症预防与治疗的循证医学研究[J].药物评价研究,2009,32(2):135-139. 被引量:15
  • 4Mendez-Sanchez N, Chavez-Tapia N C, Zamora-Valdes D, et al. Adiponectin, structure, function and pathophy- siological implications in non-alcoholic fatty liver disease [J]. Mini Rev Med Chem, 2006, 6(6): 651-656.
  • 5Yamauchi T, Kamon T, Waki H, et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase [J]. Nat Med, 2002, 8(11): 1288-1295.
  • 6Pajvani U B, Du X, Combs T P, et al. Structure function studies of the adiponectin-secreted hormone Acrp30/ adiponectin [J]. Biol Chem, 2003, 278(11): 9073 -9085.
  • 7Shapiro L, Scherer P E. The crystal structure of a complement-lq family protein suggests an evolutionary linktotumomecrosis factor [J]. Curr Biol, 1998, 8(3): 335-338.
  • 8Pajvani U B, Hankins M, Combs T P, et al. Complex distribution, not absolute amount of adiponectin, correlates with thizolidinedione-mediated mprovement in insulin sensitivity [J]. Biol Chem, 2004, 279(13): 12152-12162.
  • 9Tsao T S, Murrey H E, Hug C, et al. Oligomerization state-dependent activation of NF-kappa B signaling pathway by adipocyte complement-related protein of 30 kDa (Acrp30) [J]. Biol Chem, 2002, 277(33): 29359- 29362.
  • 10Yamauchi T, Kamon J, Ito Y, et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects [J]. Nature, 2003, 423(6941): 762-769.

二级参考文献53

  • 1Corrado A, Neve A, Maruotti N, et al. Dose-dependent metabolic effect of zol.edronate on primary human osteoblastic cell cultures[J]. Clin Exp Rheumatol, 2010, 28(6):873-879.
  • 2Mori GG, Janjacomo DM, Nunes DC, et al. Effect of zoledronic acid used in the root surface treatment of late replanted teeth: a study in rats[J]. Braz Dent J,2010,21(5): 452-457.
  • 3Leal T, Tevaarwerk A, Love R, et al. Randomized trial of adjuvant zoledronic acid in postmenopausal women with high risk breast cancer[J]. Clin Breast Cancer, 2010, 10(6): 471- 476.
  • 4Hamdy RC. Zoledronic acid: clinical utility and patient considerations in osteoporosis and low bone mass[J]. Drug Des Devel Ther, 2010,4: 321-335.
  • 5Goeree R, Blaekhouse G, Adaehi J. Cost-effectiveness of alternative treatments (or women with osteoporosis in Canada [J]. Curr Med Res Opin, 2006,22(7): 1425-1436.
  • 6Goeree R, Blackhouse G, Adachi J. Cost-effectiveness of alternative treatments for women with osteoporosis in Canada [J]. CurrMedRes Opin, 2006,22(7): 1425-1436.
  • 7Muguruma H, Yano S, Kakiuchi S, et al. Reveromycin A inhibits osteolytie bone metastasis of small cell lung cancer cells, SBC-5, through an antiosteoclastic activity [ J ]. Clin Cancer Res, 2005,11(24 Pt 1):8822-8828.
  • 8Canalis E. Mechanisms of glucocorticoid action in bone [J]. Curr Osteoporos Rep,2005,3 (3):98-102.
  • 9Vestergaard P, Re inmark L, Mosekilde L. Fracture risk associated with different types of oral corticosteroids and effect of termination of corticosteroids on the risk of fractures[J]. Calcif Tissue Int,2008,82(4) :249-257.
  • 10Kanis JA,Johansson H, Oden A, et al. A meta-analysis of prior corticosteroid use and fracture risk[J] . J Bone Miner Res,2004,19(6) :893-899.

共引文献134

同被引文献27

引证文献2

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部